Can artificial intelligence guide novice operators to obtain echocardiographic scans with limited diagnostic utility?
By A. Narang et al In this prospective, multi-centre diagnostic study by Narang et al, a cohort of 8 nurses without prior ultrasonography experience used…
View More Can artificial intelligence guide novice operators to obtain echocardiographic scans with limited diagnostic utility?
Impact of wearable devices on clinical outcomes and health care utilisation in AF patients
Summary taken directly from the American College of Cardiology Quick Takes Patients with AF who use wearable devices for detection of AF are more than…
View More Impact of wearable devices on clinical outcomes and health care utilisation in AF patients
Reversal agents for DOACs – a recent meta-analysis
By Saadia Aslam Major bleeding that requires hospitalisation occurs in 2% to 3.5% of patients that take DOACs. Some of these patients may require reversal…
View More Reversal agents for DOACs – a recent meta-analysis
Can the consent process be improved using animation?
Video update: 8 June 2021. Article originally published 7 May 2021. Patient understanding of angiography and angioplasty is often incomplete at the time of consent.…
View More Can the consent process be improved using animation?
Getting the best from the Heart Team: Guidance for the structure and function of cardiac multidisciplinary meetings
Today the British Cardiovascular Society, together with the Association for Cardiothoracic Anaesthesia and Critical Care, the British Cardiovascular Intervention Society, the British Heart Valve Society…
View More Getting the best from the Heart Team: Guidance for the structure and function of cardiac multidisciplinary meetings
Techniques to Decrease PPM Implantation Rates Post-TAVR
Kris Kumar, DO; Firas E. Zahr, MD, FACC; Harsh Golwala, MDExpert Analysis (from the ACC) Quick Takes: Decreasing the degree that the transcatheter heart valve (THV) is…
View More Techniques to Decrease PPM Implantation Rates Post-TAVR
Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…
View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients
Dr Amit Bhan examines a study on Novel Oral Anticoagulants recently published in the European Heart Journal.
View More Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients
The Expanding Role of Social Media in Cardiovascular Work
The following two articles explore the roles social media can play in the cardiovascular sector. From research, to peer-to-peer engagement to recruitment. Social media in…
View More The Expanding Role of Social Media in Cardiovascular Work
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant…
View More Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve